Fermata Advisors, LLC Amgen Inc Transaction History

Fermata Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	BUY	$309.38 - $337.38 $9,281 - $10,121	30 Added 2.34%	1,312 $422,000
Q2 2024 Jul 12, 2024	BUY	$262.75 - $319.31 $336,845 - $409,355	1,282 New	1,282 $400,000
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $194,106 - $222,137	-976 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$212.27 - $248.7 $8,915 - $10,445	-42 Reduced 4.13%	976 $208,000
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $237,784 - $263,804	1,018 New	1,018 $248,000

3,097

406M

7.56M

7.16M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Fermata Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fermata Advisors, LLC with notifications on news.